Steven E Nissen Selected Research

Atorvastatin (Lipitor)

1/2019	Association of Initial and Serial C-Reactive Protein Levels With Adverse Cardiovascular Events and Death After Acute Coronary Syndrome: A Secondary Analysis of the VISTA-16 Trial.
8/2017	Lipoprotein(a) and coronary atheroma progression rates during long-term high-intensity statin therapy: Insights from SATURN.
1/2017	Comparative effects of cholesteryl ester transfer protein inhibition, statin or ezetimibe on lipid factors: The ACCENTUATE trial.
11/2016	Coronary atheroma progression rates in men and women following high-intensity statin therapy: A pooled analysis of REVERSAL, ASTEROID and SATURN.
4/2016	Efficacy and Tolerability of Evolocumab vs Ezetimibe in Patients With Muscle-Related Statin Intolerance: The GAUSS-3 Randomized Clinical Trial.
3/2016	Comparison of PCSK9 Inhibitor Evolocumab vs Ezetimibe in Statin-Intolerant Patients: Design of the Goal Achievement After Utilizing an Anti-PCSK9 Antibody in Statin-Intolerant Subjects 3 (GAUSS-3) Trial.
8/2015	Statin-induced coronary artery disease regression rates differ in men and women.
11/2014	High-intensity statin therapy alters the natural history of diabetic coronary atherosclerosis: insights from SATURN.
11/2014	Antiatherosclerotic effects of long-term maximally intensive statin therapy after acute coronary syndrome: insights from Study of Coronary Atheroma by Intravascular Ultrasound: Effect of Rosuvastatin Versus Atorvastatin.
10/2014	Sex-related differences of coronary atherosclerosis regression following maximally intensive statin therapy: insights from SATURN.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Steven E Nissen Research Topics

Disease

80	Coronary Artery Disease (Coronary Atherosclerosis) 02/2022 - 05/2003
73	Atherosclerotic Plaque (Atheroma) 03/2022 - 02/2003
41	Atherosclerosis 12/2020 - 02/2002
35	Myocardial Infarction 03/2022 - 07/2002
28	Type 2 Diabetes Mellitus (MODY) 01/2022 - 11/2005
24	Acute Coronary Syndrome 01/2022 - 03/2000
23	Stroke (Strokes) 03/2022 - 11/2005
21	Cardiovascular Diseases (Cardiovascular Disease) 01/2022 - 03/2000
20	Coronary Disease (Coronary Heart Disease) 01/2018 - 11/2003
17	Disease Progression 02/2021 - 01/2005
15	Heart Failure 09/2022 - 05/2003
14	Unstable Angina 03/2022 - 07/2002
12	Obesity 01/2022 - 06/2006
12	Inflammation (Inflammations) 10/2020 - 02/2003
10	Hypertension (High Blood Pressure) 09/2022 - 06/2006
9	Weight Loss (Weight Reduction) 03/2022 - 04/2008
9	Diabetes Mellitus 01/2021 - 06/2010
9	Vascular Diseases (Vascular Disease) 10/2020 - 09/2007
8	Atrial Fibrillation 01/2022 - 08/2015
8	Pathologic Constriction (Stenosis) 08/2018 - 03/2003
7	Rheumatoid Arthritis 09/2022 - 04/2009
7	Body Weight (Weight, Body) 01/2022 - 04/2008
6	Osteoarthritis 09/2022 - 04/2009
6	Metabolic Syndrome (Dysmetabolic Syndrome X) 02/2022 - 07/2006
6	AIDS-Related Complex (ARC) 02/2022 - 08/2014
5	Arthritis (Polyarthritis) 09/2022 - 04/2009
5	Neoplasms (Cancer) 01/2022 - 01/2009
5	Dyslipidemias (Dyslipidemia) 12/2020 - 03/2007
4	COVID-19 03/2022 - 08/2020
4	Chest Pain (Chest Pains) 01/2019 - 03/2000
4	Thrombosis (Thrombus) 04/2012 - 08/2006
3	ST Elevation Myocardial Infarction 01/2022 - 02/2003
3	Hypoglycemia (Reactive Hypoglycemia) 01/2020 - 04/2008
3	Ischemia 01/2019 - 03/2000
3	Pancreatitis 01/2018 - 10/2013
2	Hypertrophic Cardiomyopathy (Hypertrophic Obstructive Cardiomyopathy) 12/2022 - 01/2021
2	Infections 03/2022 - 10/2020
2	Cardiac Arrhythmias (Arrythmia) 01/2022 - 01/2021
2	Aortic Valve Stenosis (Aortic Stenosis) 01/2022 - 05/2003
2	Respiratory Insufficiency (Respiratory Failure) 11/2021 - 10/2020

Drug/Important Bio-Agent (IBA)

57	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2022 - 02/2003
33	LipidsIBA 02/2022 - 11/2003
27	LDL CholesterolIBA 01/2020 - 01/2005
25	HDL CholesterolIBA 03/2022 - 11/2003
25	oxidized low density lipoproteinIBA 01/2022 - 04/2006
24	Atorvastatin (Lipitor)FDA Link 01/2019 - 03/2004
20	C-Reactive ProteinIBA 10/2020 - 10/2003
19	omega-Chloroacetophenone (Mace)IBA 03/2022 - 05/2010
19	Rosuvastatin Calcium (Crestor)FDA Link 08/2017 - 04/2006
11	evacetrapibIBA 10/2020 - 11/2011
10	Triglycerides (Triacylglycerol)IBA 03/2022 - 03/2007
10	Lipoproteins (Lipoprotein)IBA 01/2018 - 01/2005
9	Cholesterol Ester Transfer ProteinsIBA 01/2020 - 12/2008
8	Celecoxib (Celebrex)FDA Link 09/2022 - 04/2009
8	Ibuprofen (Motrin)FDA LinkGeneric 09/2022 - 04/2009
8	Naproxen (Naprosyn)FDA LinkGeneric 09/2022 - 04/2009
8	CholesterolIBA 02/2022 - 02/2007
8	Pharmaceutical PreparationsIBA 01/2022 - 09/2007
8	evolocumabIBA 01/2022 - 06/2016
8	CalciumIBA 01/2021 - 01/2007
8	HDL LipoproteinsIBA 12/2020 - 03/2006
8	Apolipoprotein A-I (Apolipoprotein A1)IBA 02/2016 - 11/2003
7	Insulin (Novolin)FDA Link 02/2022 - 04/2008
7	Phenobarbital (Luminal)FDA Link 08/2018 - 03/2003
6	Lipoprotein(a)IBA 01/2022 - 08/2017
6	alogliptinIBA 01/2020 - 10/2011
6	Pioglitazone (Actos)FDA Link 01/2019 - 11/2005
6	Biomarkers (Surrogate Marker)IBA 01/2017 - 01/2005
5	LDL Lipoproteins (beta Lipoproteins)IBA 12/2020 - 01/2005
5	ApolipoproteinsIBA 01/2018 - 02/2007
5	Hypoglycemic Agents (Hypoglycemics)IBA 01/2016 - 04/2008
5	Enalapril FDA LinkGeneric 04/2012 - 11/2004
5	Amlodipine (Norvasc)FDA LinkGeneric 04/2012 - 11/2004
5	Pravastatin (Pravachol)FDA LinkGeneric 07/2008 - 03/2004
4	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 09/2022 - 04/2009
4	Apolipoproteins B (ApoB)IBA 12/2020 - 07/2008
3	Dihydrotachysterol (AT 10)IBA 03/2022 - 01/2020
3	Glycated Hemoglobin (Glycosylated Hemoglobin)IBA 11/2021 - 01/2011
3	Proprotein Convertase 9IBA 02/2021 - 12/2016
3	TroponinIBA 01/2021 - 03/2000
3	Liraglutide FDA Link 01/2020 - 11/2013
3	Proteins (Proteins, Gene)FDA Link 01/2019 - 11/2007
3	apabetaloneIBA 02/2016 - 03/2011
3	Dipeptidyl-Peptidase IV InhibitorsIBA 01/2016 - 10/2011
3	Peroxidase (Myeloperoxidase)IBA 02/2014 - 10/2003
3	Phospholipids (Phosphatides)FDA LinkGeneric 01/2014 - 11/2003
3	Antihypertensive Agents (Antihypertensives)IBA 04/2012 - 11/2004
3	EnzymesIBA 07/2009 - 10/2003
3	Troponin T (Troponin T1)IBA 10/2003 - 03/2000
2	Cyclooxygenase 2 Inhibitors (COX-2 Inhibitors)IBA 09/2022 - 11/2012
2	Anti-Arrhythmia AgentsIBA 01/2022 - 01/2021
2	Small Interfering RNA (siRNA)IBA 01/2022 - 01/2022

Therapy/Procedure

82	Therapeutics 12/2022 - 05/2003
14	Bariatric Surgery 03/2022 - 04/2012
8	Gastrectomy 03/2022 - 04/2012
8	Gastric Bypass (Roux-en-Y Gastric Bypass) 03/2022 - 04/2012
6	Glycemic Control 03/2022 - 09/2007
5	Percutaneous Coronary Intervention 08/2020 - 02/2003
3	Drug Therapy (Chemotherapy) 01/2022 - 12/2020
2	Cryosurgery 01/2022 - 01/2021